EDGAR Filing Documents for 0001558370-23-007267

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001558370-23-007267

Filing Date

2023-04-28

Accepted

2023-04-28 16:06:46

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA14A	tmb-20230428xdefa14a.htm	DEFA14A	17682
2	GRAPHIC	tmb-20230428xdefa14a_bg001.jpg	GRAPHIC	212865
3	GRAPHIC	tmb-20230428xdefa14a_bg002.jpg	GRAPHIC	203192
	Complete submission text file	0001558370-23-007267.txt		591933

Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107

Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316

Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)